Evidence map›Paper›PMID 21858156›Full record

ArticlePloS one2011

Lifespan-extending effects of royal jelly and its related substances on the nematode Caenorhabditis elegans.

Yoko Honda, Yasunori Fujita, Hiroe Maruyama, Yoko Araki, Kenji Ichihara, Akira Sato, Toshio Kojima, Masashi Tanaka, Yoshinori Nozawa, Masafumi Ito and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Role of Vitamin B in Healthy Ageing and Disease.Sub-cellular biochemistry · 2024
    Review
  9. Hydroxylation of Fatty Acids by Lactic Acid Bacteria.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Natural Compounds Attenuate Denervation-Induced Skeletal Muscle Atrophy.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Plant and fungal products that extend lifespan inMicrobial cell (Graz, Austria) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yoko HondaDepartment of Genomics for Longevity and Health, Tokyo Metropolitan Institute of Gerontology, Sakaecho, Itabashiku, Tokyo, Japan.
Yasunori Fujita
Hiroe Maruyama
Yoko Araki
Kenji Ichihara
Akira Sato
Toshio Kojima
Masashi Tanaka
Yoshinori Nozawa
Masafumi Ito
Shuji Honda
Nagara Medical Center · JPTokyo Metropolitan Institute of Gerontology · JPHamamatsu University School of Medicine · JPTokai Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the most important challenges in the study of aging is to discover compounds with longevity-promoting activities and to unravel their underlying mechanisms. Royal jelly (RJ) has been reported to possess diverse beneficial properties. Furthermore, protease-treated RJ (pRJ) has additional pharmacological activities. Exactly how RJ and pRJ exert these effects and which of their components are responsible for these effects are largely unknown. The evolutionarily conserved mechanisms that control longevity have been indicated. The purpose of the present study was to determine whether RJ and its related substances exert a lifespan-extending function in the nematode Caenorhabditis elegans and to gain insights into the active agents in RJ and their mechanism of action. PRINCIPAL

findingsWe found that both RJ and pRJ extended the lifespan of C. elegans. The lifespan-extending activity of pRJ was enhanced by Octadecyl-silica column chromatography (pRJ-Fraction 5). pRJ-Fr.5 increased the animals' lifespan in part by acting through the FOXO transcription factor DAF-16, the activation of which is known to promote longevity in C. elegans by reducing insulin/IGF-1 signaling (IIS). pRJ-Fr.5 reduced the expression of ins-9, one of the insulin-like peptide genes. Moreover, pRJ-Fr.5 and reduced IIS shared some common features in terms of their effects on gene expression, such as the up-regulation of dod-3 and the down-regulation of dod-19, dao-4 and fkb-4. 10-Hydroxy-2-decenoic acid (10-HDA), which was present at high concentrations in pRJ-Fr.5, increased lifespan independently of DAF-16 activity. CONCLUSIONS/SIGNIFICANCE: These results demonstrate that RJ and its related substances extend lifespan in C. elegans, suggesting that RJ may contain longevity-promoting factors. Further analysis and characterization of the lifespan-extending agents in RJ and pRJ may broaden our understanding of the gene network involved in longevity regulation in diverse species and may lead to the development of nutraceutical interventions in the aging process.

Indexed as

Active Transport, Cell NucleusAgingAnimalsBeesCaenorhabditis elegansCaenorhabditis elegans ProteinsCell NucleusChromatographyDose-Response Relationship, DrugFatty AcidsFatty Acids, MonounsaturatedForkhead Transcription FactorsGene Expression ProfilingGene Expression RegulationGreen Fluorescent ProteinsLongevity10-hydroxy-2-decenoic acidCaenorhabditis elegans Proteinsdaf-16 protein, C elegansFatty AcidsFatty Acids, MonounsaturatedForkhead Transcription FactorsGreen Fluorescent ProteinsPeptide HydrolasesRoyal JellyTranscription Factors

Identifiers

PMID21858156
PMCPMC3153499
OpenAlexW2081003655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.